Research in Australia finds a copper based drug called Cu(ATSM) makes dramatic improvements in the condition of mice with Alzheimer's. It apparently restores the brain's ability to get rid of waste byproducts. The study, published in ACS Chemical Neuroscience reports:
By improving the pumps, the brain can finally clear out the trapped waste. Over 56 days, the treatment reduced toxic amyloid-beta by 42% and improved spatial learning by nearly 44%.
Cu(ATSM) is a copper compound with anti-inflammatory and neuroprotective properties that has already progressed to clinical testing for conditions like Parkinson's and ALS.
It is early days, but this testing of the drug in humans (i.e., "clinical testing") sounds promising for early off-label use. Hat tip to Instapundit for the link.